Page 2 of 17.
In total there are 168 English news articles.
Despite all the research effort to target neurodegeneration, there is still a lack of satisfactory drug-mediated treatments for Parkinson´s disease. Therefore, there is an urgent need for new treatment modalities such as neurofeedback technology that target diseases of the brain. Neurofeedback is based on neurological compensatory mechanisms that help our brain to adjust to ever-changing conditions, including Parkinson´s disease.
A renewed and improved database for the genes of the major histocompatibility complex of different animal species
Our body must recognize viruses, bacteria and parasites and distinguish these from its tissues to render the pathogens harmless without attacking the own tissues. A very complex part of the immune system is responsible for this, the major histocompatibility complex (MHC).
We are pleased to present the BPRC 2016 Annual Scientific Report
BPRC researchers have previously shown that an EBV-related virus can disrupt the immune system of monkeys and can therebye cause multiple sclerosis (MS) (http://www.bprc.nl/en/article/infection-with-a-virus-related-to-epstein-barr-dysregulates-the-immune-system-of-monkeys). This work has been described previously in the Multiple Sclerosis Journal - Experimental, Translational and Clinical
Each cell in the body contains the same DNA, the genetic code that determines which proteins may be produced by a cell. However, the proteins that are produced differ significantly between cells of different tissues. Similarly, the timing of expression and the expression levels are regulated in a complex manner at different levels. For example, certain molecules such as methyl groups can bind to specific parts of the DNA. Such genetic modification often leads to suppression of the transcription of the gene and the associated protein production.
Currently, malaria is treated with a mixture of medicines including artemisinin, isolated from a herb that has been used for a long time in traditional Chinese medicine.
The only vaccine available for tuberculosis (TB) today - M.bovis Bacille Calmette-Guérin, or BCG for short - is known to be variably protective in different human populations. In particular, epidemiology studies show that adolescents and adults in high-burden TB areas do not benefit from standard intradermal BCG vaccination at all, whereas on the other hand adult vaccination in low mycobacterial exposure areas can lead to protective immunity.
An effective vaccine evokes a powerful immune response against a pathogen, resulting in removal of infiltrating pathogens and prevention of illness.
In the search for therapies for multiple sclerosis (MS), animal models are still needed. However, new therapies that target specific processes can only be tested in animal models if these processes are comparable between patients and the animal model.
Myasthenia gravis is an autoimmune disease in which antibodies disturb the transmission of electrical signals from the nerves to the muscle; This causes weaknesses of the muscles. BPRC researchers have contributed to research into a new therapy for this disease.